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Abstract 34 
Pregnancy is associated with significant changes in vitamin D metabolism, notably increased 35 
maternal serum levels of active vitamin D, 1,25-dihydroxyvitamin (1,25(OH)2D). This appears 36 
to be due primarily to increased renal activity of the enzyme 25-hydroxyvitamin D-1α-37 
hydroxylase (CYP27B1) that catalyzes synthesis of 1,25(OH)2D, but CYP27B1 expression is 38 
also prominent in both the maternal decidua and fetal trophoblast components of the 39 
placenta. The precise function of placental synthesis of 1,25(OH)2D remains unclear, but is 40 
likely to involve localised tissue-specific responses with both decidua and trophoblast also 41 
expressing the vitamin D receptor (VDR) for 1,25(OH)2D. We have previously described 42 
immunomodulatory responses to 1,25(OH)2D by diverse populations of VDR-expressing 43 
cells within the decidua. The aim of the current review is to detail the role of vitamin D in 44 
pregnancy from a trophoblast perspective, with particular emphasis on the potential role of 45 
1,25(OH)2D as a regulator of trophoblast invasion in early pregnancy. Vitamin D-deficiency is 46 
common in pregnant women, and a wide range of studies have linked low vitamin D status to 47 
adverse events in pregnancy. To date most of these studies have focused on adverse 48 
events later in pregnancy, but the current review will explore the potential impact of vitamin 49 
D on early pregnancy, and how this may influence implantation and miscarriage.  50 
 51 
 52 
 53 
 54 
 55 
 56 
 57 
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Introduction 58 
The human placenta is a vital organ without which the mammalian fetus cannot survive. It 59 
forms the interface between the mother and fetus, supplying the fetus with oxygen, nutrients, 60 
excreting waste products, whilst protecting against maternal immunologic attack. The main 61 
functions of the placenta can be broadly categorised into transport and metabolism, 62 
protection and endocrine (Gude, et al. 2004). The complex architecture of the placenta, 63 
bounded by the maternal aspect (basal plate) and the fetal aspect (chorionic plate), houses 64 
an abundance of the fundamental functional unit of the placenta, the chorionic villus, where 65 
all nutritional-waste exchange between the maternal blood and the fetal circulation occurs.  66 
As well as facilitating a good maternal blood supply for nutrition-waste exchange, and 67 
orchestrating endocrine mediators of pregnancy to maintain maternal physiological changes 68 
for an optimal environment for fetal development, the placenta also acts to protect the fetus 69 
from xenobiotic materials and infectious agents (Gude et al. 2004; Moore, et al. 1999; 70 
Rudge, et al. 2009; Yang 1997). Successful development of the placenta involves two 71 
distinct mechanisms: implantation of the blastocyst, initiated by attachment of the embryo to 72 
the maternal endometrial epithelium, and invasion of fetal trophoblast cells into the maternal 73 
endometrium to facilitate maternal-fetal exchange of nutrients, gases and waste. The diverse 74 
mechanisms associated with the regulation of trophoblast invasion have been well 75 
documented (Menkhorst, et al. 2016).  The aim of the current review is to provide an 76 
overview of these early events in placental development, with particular emphasis on the 77 
potential role of vitamin D as a determinant of early placental development through effects 78 
on trophoblast cells, particularly via effects of vitamin D on trophoblast invasion. 79 
 80 
Vitamin D and pregnancy 81 
Despite its long-standing association with rickets and osteoporosis, vitamin D has become 82 
increasingly recognized as a pluripotent regulator of biological functions above and beyond 83 
its classical effects on bone and calcium homeostasis.  Expression of vitamin D receptor 84 
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(VDR) for the active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D), as well as the 85 
1α-hydroxylase enzyme that synthesizes 1,25(OH)2D (CYP27B1), has been reported for 86 
various tissues that can be broadly termed ‘barrier sites’ (Jones, et al. 1998; Townsend, et 87 
al. 2005), indicating that localized responses to vitamin D may be a key feature of these 88 
tissues.  Prominent amongst these barrier sites is the placenta, acting as the interface 89 
between mother and fetus. Historically, the placenta was one of the first extra-renal tissues 90 
shown to be capable of synthesizing 1,25(OH)2D, with CYP27B1 activity detectable in both 91 
maternal decidua and fetal trophoblast (Gray, et al. 1979; Weisman, et al. 1979).  Initially, 92 
this was linked to the rise in maternal serum 1,25(OH)2D that occurs at the end of the first 93 
trimester of pregnancy.  However, studies of CYP27B1-deficient animals and an anephric 94 
pregnant woman indicated that this is not likely to be the case (Kovacs and Kronenberg 95 
1997).  Instead, the presence of VDR in the placenta suggests that vitamin D functions in 96 
tissue-specific fashion at the fetal-maternal interface (Bruns and Bruns 1983). One possible 97 
explanation is that 1,25(OH)2D acts as a regulator of placental calcium transport (Bruns and 98 
Bruns 1983), but a placental immunomodulatory function has also been proposed (Liu and 99 
Hewison 2012). Moreover, the rapid induction of VDR and CYP27B1 early in pregnancy 100 
(Zehnder, et al. 2002) suggests that vitamin D may play a more fundamental role in the 101 
process of conception, implantation and development of the placenta itself.         102 
 103 
Vitamin D and implantation 104 
To date the precise role of vitamin D in the process of implantation remains unclear.  105 
Nevertheless, vitamin D has a biologically plausible role in female reproduction and 106 
implantation process.  1,25(OH)2D has been shown to regulate expression of the homeobox 107 
gene HOXA10 in human endometrial stromal cells (Du, et al. 2005b). HOXA10 is important 108 
for the development of the uterus during fetal life and, later in adulthood, is essential for 109 
endometrial development, allowing uterine receptivity to implantation (Bagot, et al. 2000). 110 
Interestingly, animal studies have shown that vitamin D-deficiency reduces mating success 111 
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and fertility in female rats. Female rats fed with a vitamin D-deficient diet are capable of 112 
reproduction, but overall fertility is reduced including the failure of implantation (Halloran and 113 
DeLuca 1980). This was shown to be corrected by administration of 1,25(OH)2D (Kwiecinksi, 114 
et al. 1989), but also by use of diets high in calcium, phosphate and lactose (Johnson and 115 
DeLuca 2002), suggesting that the fertility effects of vitamin D may be due to indirect effects 116 
on mineral homeostasis. Other studies using knockout mouse models have further 117 
highlighted the importance of the vitamin D metabolic and signalling system in the process of 118 
implantation, with Vdr -/- and Cyp27b1 -/- female mice both presenting with uterine 119 
hypoplasia and infertility (Panda, et al. 2001; Yoshizawa, et al. 1997). Conversely, injection 120 
of 1,25(OH)2D has been shown to increase uterine weight and promote endometrial to 121 
decidual differentiation (Halhali, et al. 1991).   122 
 123 
As well as regulating uterine and decidual development, vitamin D may also influence 124 
implantation indirectly via its well-known immunomodulatory actions. Regulation of immune 125 
function at the maternal-fetal interface involves a heterogeneous population of innate and 126 
adaptive immune cell subsets. Thus throughout pregnancy, decidual synthesis of 127 
1,25(OH)2D has the potential to influence uterine natural killer cells, dendritic cells, 128 
macrophages, and T-cells  (Evans, et al. 2004; Tamblyn, et al. 2015). Notable effects include 129 
inhibition of Th1 cytokines and promotion of Th2 cytokines (Gregori, et al. 2001), which are 130 
known to play a significant role in the process of implantation (Piccinni, et al. 2000; Zehnder 131 
et al. 2002).  Purification of decidual cells into non-adherent stromal cells and adherent cells, 132 
which include decidual macrophages and uterine natural killer cells, has shown that 133 
adherent cells demonstrate a greater capacity for 1,25(OH)2D production (Kachkache, et al. 134 
1993). Furthermore, first-trimester decidual cells treated with either 25OHD- or 1,25(OH)2D 135 
demonstrate significant induction of antibacterial protein cathelicidin and β-defensins (Evans, 136 
et al. 2006; Liu, et al. 2009). Since similar effects of vitamin D are observed in peripheral 137 
monocytes, an equivalent innate antimicrobial responsivity is postulated to exist at the 138 
maternal-fetal interface (Liu and Hewison 2012).  139 
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 140 
Vitamin D metabolism and function in trophoblast cells 141 
The organisation of maternal and fetal cells within the developing placenta has been well 142 
documented elsewhere (Oreshkova, et al. 2012; Vigano, et al. 2003), and is represented 143 
schematically in Figure 1. Both the maternal decidua and fetal trophoblast components of 144 
the placenta (including syncytiotrophoblast and invasive extravillous trophoblast [EVT]) 145 
express CYP27B1 (Zehnder et al. 2002), and are able to produce detectable levels of 146 
1,25(OH)2D (Gray et al. 1979; Weisman et al. 1979). The resulting tissue concentrations of 147 
1,25(OH)2D appear to be significantly higher in the decidua (Tamblyn, et al. 2017), but the 148 
coincident expression of VDR in trophoblast as well as decidua (Evans et al. 2004) means 149 
that multiple cell types within the placenta are capable of responding to the locally 150 
synthesized 1,25(OH)2D, either in an autocrine or paracrine fashion.  151 
 152 
To date, studies of the physiological impact of decidual-trophoblast 1,25(OH)2D production 153 
have focused primarily on trophoblast cells, using both primary cultures of EVT and 154 
trophoblast cells lines. Primary cultures of human syncytiotrophoblast express CYP27B1 and 155 
are able to synthesize 1,25(OH)2D (Diaz, et al. 2000), and also express VDR (Pospechova, 156 
et al. 2009). However, in choriocarcinoma trophoblast cell lines such as BeWo and JEG-3, 157 
expression of VDR is low, with analysis of the effects of chromatin remodelling agents 158 
suggesting that this may be due to epigenetic suppression of VDR in these cells 159 
(Pospechova et al. 2009).  Further studies to assess the impact of differentiation of cultured 160 
trophoblast cells have been carried out using cyclic AMP (cAMP) to mimic the process of 161 
syncytialisation (Keryer, et al. 1998). Expression of hCG is elevated by cAMP in trophoblast 162 
cells, and this was associated with decreased expression of CYP27B1, with VDR expression 163 
being unaffected (Avila, et al. 2007), suggesting that presence of the vitamin D metabolic 164 
and signalling pathways in the placenta is differentiation-sensitive. The JEG-3 trophoblast 165 
cell line has also been reported to express CYP27B1, but synthesis of 1,25(OH)2D by these 166 
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cells appears to be significantly less than observed with primary trophoblast cells and 167 
unaffected by cAMP (Pospechova et al. 2009).  In addition to cAMP, inflammatory cytokines 168 
(Noyola-Martinez, et al. 2014), and insulin-like growth factor I (Halhali, et al. 1999) also 169 
stimulate trophoblast expression of CYP27B1 and synthesis of 1,25(OH)2D. 170 
 171 
The vitamin D catabolic enzyme CYP24A1 has been reported to be undetectable in 172 
trophoblast cells, consistent with methylation epigenetic silencing of this gene in the human 173 
placenta (Novakovic, et al. 2009). This suggests that synthesis of 1,25(OH)2D by trophoblast 174 
cells is not subject to the same catabolic feedback control observed in other VDR-expressing 175 
tissues. However, other studies have shown that trophoblast expression of CYP24A1 is 176 
increased following treatment with cAMP (Avila et al. 2007). In addition, studies using the 177 
Hyp mouse model, which has elevated circulating levels of the positive regulator of 24-178 
hydroxylase fibroblast growth factor 23 (FGF23), showed elevated placental expression of 179 
CYP24A1 mRNA in these mice (Ma, et al. 2014; Ohata, et al. 2014).  Likewise, direct 180 
injection of FGF23 into normal placentas from wild type mice also induced expression of 181 
CYP24A1 (Ohata et al. 2014). This appears to be mediated via trophoblast expression of 182 
fibroblast growth factor receptor 1 and its co-receptor α-klotho by trophoblast, suggesting 183 
that catabolism via CYP24A1 plays an as yet undefined role in mediating trophoblast effects 184 
of vitamin D.  185 
 186 
Despite a wide range of studies showing regulation and activity of vitamin D metabolic 187 
enzymes in primary trophoblast cells and trophoblast cell lines, the principal functional 188 
analysis of vitamin D in these cells has centered on responses to 1,25(OH)2D. Initial 189 
experiments using JEG-3 cells described stimulation of calcium uptake (Tuan, et al. 1991), 190 
and the regulation of the cytosolic calcium binding protein calbindin-D28K (Belkacemi, et al. 191 
2005) by 1,25(OH)2D, consistent with a role for vitamin D in the endocrinology of placental 192 
calcium homeostasis. However, subsequent investigations of trophoblast cells and 193 
1,25(OH)2D have explored other mechanisms associated with placental endocrine function. 194 
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These reports include the stimulation of human placental lactogen synthesis and release 195 
(Stephanou, et al. 1994), hCG expression (Barrera, et al. 2008), and the regulation of 196 
estradiol and progesterone synthesis (Barrera, et al. 2007).   197 
 198 
In recent years, our perspective on vitamin D and trophoblast function has been expanded to 199 
include studies of immunomodulatory function. In primary trophoblast cells and trophoblast 200 
cell lines, 1,25(OH)2D has been shown to potently stimulate expression of the antibacterial 201 
protein cathelicidin (Liu et al. 2009), whilst also suppressing inflammatory responses to 202 
tumor necrosis factor α (TNFα) (Diaz, et al. 2009). Similar anti-inflammatory responses to 203 
1,25(OH)2D have also been reported using trophoblasts from women with the inflammatory 204 
disorders of pregnancy, preeclampsia (Noyola-Martinez, et al. 2013), and antiphospholipid 205 
syndrome (APS) (Gysler, et al. 2015). In recent studies the anti-inflammatory effects of 206 
1,25(OH)2D on trophoblasts have been reported to include attenuation of oxidative stress-207 
induced microparticle release from preeclampsia trophoblastic cells (Xu, et al. 2017), further 208 
underlining the importance of this facet of vitamin D function within the placenta. In vivo, 209 
studies using Cyp27b1-/- and Vdr-/- mice have shown that loss of both alleles for either of 210 
these genes on the fetal side of the placenta alone was sufficient to dramatically exacerbate 211 
anti-inflammatory responses to lipopolysaccharide (LPS) immune challenge (Liu, et al. 212 
2011). Thus, in addition to the active immune cell function classically observed in the 213 
maternal decidua, trophoblast cells also appear to make a major contribution to the 214 
regulation of placental inflammation. 215 
    216 
A role for vitamin D in EVT invasion? 217 
Controlled invasion of fetal cytotrophoblast and differentiated EVT cells into the maternal 218 
decidua and myometrium in the first trimester of pregnancy is a key process in placentation, 219 
and is essential for successful pregnancy.  A complex network of communications among 220 
trophoblast, decidual stromal, and immune cells is reported to facilitate implantation and 221 
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maintenance of pregnancy, with key roles in tissue remodelling, cell trafficking, and immune 222 
tolerance being evident (Oreshkova et al. 2012). The mechanisms underpinning these 223 
processes have received increasing attention since abnormal placentation due to shallow 224 
invasion of EVT can cause important pregnancy disorders such as miscarriage (Ball, et al. 225 
2006), pre-eclampsia (Caniggia, et al. 2000), fetal growth restriction, pre-term birth, and 226 
stillbirth (Reddy, et al. 2006) (Goldman-Wohl and Yagel 2002; Kadyrov, et al. 2006; 227 
Kaufmann, et al. 2003). By contrast, unrestricted invasion resulting from a failure to restrain 228 
the invading cytotrophoblast is associated with premalignant conditions such as malignant 229 
choriocarcinomas and invasive mole (Caniggia et al. 2000; Ringertz 1970), and can lead to 230 
aberrant placentation such as pathological adhesion to the myometrium (placenta accreta), 231 
extension into the myometrium (placenta increta), or invasion through the myometrium into 232 
adjacent organs (placenta percreta) (Khong 2008).  233 
 234 
In recent studies we have shown that human EVT isolated from first trimester pregnancies 235 
are a target for both 25(OH)D and 1,25(OH)2D (Chan, et al. 2015). In ex vivo experiments 236 
both vitamin D metabolites promoted the invasion of EVT through Matrigel, with zymographic 237 
analysis showing that this effect involves enhanced expression of the matrix 238 
metalloproteinases pro-MMP2 and pro-MMP9 (Chan et al. 2015). These observations are in 239 
direct contrast to previously published studies describing 1,25(OH)2D inhibition of matrix 240 
invasion by tumor cells  (Bao, et al. 2006). In this case the primary mode of action for 241 
1,25(OH)2D was indirect suppression of MMPs via enhanced tissue inhibitor of 242 
metalloproteinase-1 (TIMP-1) expression. However, in other reports, low vitamin D status 243 
has been shown to be associated with elevated circulating MMP2 and MMP9 (Timms, et al. 244 
2002). Suppression of a variety of MMPs, including MMP2 and MMP9, by 1,25(OH)2D has 245 
also been described for primary cultures of human uterine fibroid cells and uterine fibroid cell 246 
lines (Halder, et al. 2013). Thus, the pro-invasive effects of vitamin D on EVTs appear to be 247 
quite distinct to pregnancy and the placenta.    248 
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 249 
The concept of vitamin D as a regulator of cellular motility and invasion is not novel and has 250 
been extensively reported in cancer states (Krishnan, et al. 2012; Leyssens, et al. 2014; Ma, 251 
et al. 2016), where effects of vitamin D have been related to modulation of epithelial 252 
mesenchymal transition (EMT) (Chen, et al. 2015; Fischer and Agrawal 2014; Hou, et al. 253 
2016). Interestingly, this effect of vitamin D has not been observed in non-pathophysiological 254 
states or during embryogenesis. For example, vitamin D is known to inhibit invasion and 255 
motility of ovarian cancer and teratocarcinoma cell lines, but does not affect these cellular 256 
characteristics in the non-neoplastic ESD3 murine embryonic cell line (Abdelbaset-Ismail, et 257 
al. 2016). The precise molecular mechanisms that mediate migration and invasion regulation 258 
by vitamin D remain unclear, although several different pathways have been studied. 259 
Notably, vitamin D has been shown to regulate the actin cytoskeleton in numerous cell 260 
types. In osteoblast-like cells, vitamin D promotes actin polymerisation as part of its 261 
transcriptional induction of fibroblast growth factor 23 (Fajol, et al. 2016). In endometrial 262 
cells, vitamin D treatment has also been shown to induce changes in actin architecture, 263 
through regulation of the RAc1/Pak1 axis (Zeng, et al. 2016). It is not clear if such responses 264 
are also seen in trophoblast cells during placental development, but vitamin D has been 265 
shown to rescue motility defects in fetal endothelial colony forming cell function of umbilical 266 
vein endothelial cells derived from pregnancies complicated by preeclampsia (von Versen-267 
Hoynck, et al. 2014) and gestational diabetes (Gui, et al. 2015). 268 
 269 
Effects of vitamin D on EVT invasion and migration may also be mediated indirectly via 270 
effects on other known EVT regulators. 1,25(OH)2D has been shown to abolish S1P 271 
mediated inhibition of migration via suppression of S1PR2 in trophoblast cell lines Swan-71 272 
and JEG-3 (Westwood 2017). 1,25(OH)2D has also been shown to stimulate 273 
hCG expression and secretion via a cAMP/PKA-mediated signalling pathway (Barrera et al. 274 
2008). Although hCG is a potent regulator of trophoblast motility and invasion (Chen, et al. 275 
2011; Evans 2016), it is unclear whether changes in hCG expression are specifically 276 
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required for effects of vitamin D on trophoblast invasion. In a similar fashion, 1,25(OH)2D3 277 
has been shown to positively regulate progesterone synthesis by human trophoblast cells 278 
from term placenta (Barrera et al. 2007). In HTR8/SVneo trophoblast cells, which have been 279 
reported to consist of a mixed population of cells, progesterone appears to suppress 280 
trophoblast motility and invasion (Chen et al. 2011). Thus, 1,25(OH)2D may exert indirect 281 
effects on trophoblast invasion, although it is still not clear whether these effects are pro-282 
migratory. Indirect actions of vitamin D on EVT function may also stem from effects on 283 
placental cell differentiation. Recent studies have shown that inactivation of VDR in 284 
trophoblastic BeWo cells resulted in increased trophoblast differentiation and syncytium 285 
formation (Nguyen, et al. 2015). In a similar fashion vitamin D may also influence EVT 286 
invasion and motility indirectly by targeting the development of cells on the maternal side of 287 
the placenta. Endometrial stromal cells treated with 1,25(OH)2D have elevated expression of 288 
specific genes, including HOXA10 (Du, et al. 2005a), which are known to be involved in the 289 
regional development of uterine decidualization and embryo implantation by controlling 290 
downstream target genes. The complex circuitry of vitamin D metabolism and function 291 
involved in mediating direct or indirect effects on EVT invasion and migration has still to be 292 
fully elucidated and is likely to be a key component of future studies of vitamin D in 293 
pregnancy. 294 
 295 
Vitamin D and trophoblast function: clinical implications 296 
Irrespective of proposed functional targets, vitamin D-dysregulation during pregnancy has 297 
been linked to adverse effects on placental function and pregnancy in general. In 2010 the 298 
Institute of Medicine (IOM) defined vitamin deficiency as serum concentrations of 25(OH)D 299 
less than 20 ng/ml (50 nM) (Holick, et al. 2011a). Subsequently the Endocrine Society 300 
issued slightly different guidelines, defining vitamin D-insufficiency as being serum 25(OH)D 301 
levels below 30 ng/ml (75 nM) (Holick, et al. 2011b). Against this backdrop, several recent 302 
publications have highlighted the prevalence of low serum concentrations of 25(OH)D (less 303 
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than 25 nM) in pregnant women: 20% of pregnant women in the UK (Javaid, et al. 2006), 304 
25% in the UAE (Dawodu, et al. 1997), 80% in Iran (Bassir, et al. 2001), 45% in northern 305 
India (Sachan, et al. 2005), 60% in New Zealand (Eagleton and Judkins 2006) and 60–84% 306 
of pregnant non-Western women in the Netherlands (van der Meer, et al. 2006). It remains 307 
unclear if this reflects simply a normal physiological drop in vitamin D concentrations during 308 
pregnancy or if pregnancy is a stress test which can exacerbate and unmask pathological 309 
vitamin D deficiency.   310 
 311 
Vitamin D deficiency in pregnant women has been shown to be associated with increased 312 
risk for pregnancy complications (Lewis, et al. 2010). These include preeclampsia (Bodnar, 313 
et al. 2007b), fetal growth restriction, small for gestational age fetus (Bodnar, et al. 2010), 314 
bacterial vaginosis (Bodnar, et al. 2009), and gestational diabetes mellitus  (Maghbooli, et al. 315 
2008; Zhang, et al. 2008). Maternal vitamin D-deficiency has also been linked to adverse 316 
effects in offspring, including reduced bone density (Javaid et al. 2006) and childhood rickets 317 
(Wagner and Greer 2008), as well as increased risk of asthma (Camargo, et al. 2007), and 318 
schizophrenia (McGrath 2001).  319 
 320 
The impact of vitamin D status on early events in pregnancy has also been studied. In 321 
northern countries, where there is a strong seasonal contrast in light exposure and UVB-322 
induced vitamin D production in skin, conception rates are decreased during winter months, 323 
with rates rising during summer and an increased birth rate in spring (Rojansky, et al. 1992). 324 
Interestingly, ovulation rates and endometrial receptivity also appear to be reduced during 325 
long dark winters in northern countries (Rojansky, et al. 2000), which may be explained in 326 
part by seasonal variations in vitamin D levels. With this in mind, several observational 327 
studies have investigated the potential impact of vitamin D on in vitro fertilisation (IVF), albeit 328 
with largely conflicting outcomes.  In a study of  infertile women undergoing IVF, those with 329 
higher levels of 25(OH)D in serum and follicular fluid, were more likely to achieve pregnancy 330 
following IVF, and high vitamin D levels were also shown to improve the parameters of 331 
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controlled ovarian hyperstimulation (Ozkan, et al. 2010). Aleyasin et al. found no significant 332 
association between 25(OH)D levels in serum and follicular fluid with IVF outcomes 333 
(Aleyasin, et al. 2011). However, this did not include any women with a serum vitamin D 334 
level >50nmol/L. In another study of 100 women undergoing IVF, serum concentrations of 335 
25(OH)D were positively associated with fertilization rate (Abadia, et al. 2016). However, 336 
serum 25(OH)D was unrelated to the probability of pregnancy or live birth after IVF (Abadia 337 
et al. 2016). Anifandis et al. investigated 101 women who received IVF-intracytoplasmic 338 
sperm injection (ICSI) ovarian stimulation cycles. In this study, women with vitamin D-339 
sufficiency (25(OH)D level >30 ng/ml in follicular fluid) had a lower quality of embryos and 340 
were less likely to achieve clinical pregnancy, compared with women with insufficient 341 
(follicular fluid 25(OH)D level 20.10 to 30 ng/ml) or deficient vitamin D status (follicular fluid 342 
25(OH)D level <20 ng/ml) (Anifandis, et al. 2010).  343 
 344 
Elucidation of the immunomodulatory effects of 1,25(OH)2D has led to the suggestion that 345 
vitamin D might have a role in protecting against spontaneous abortion (Bubanovic 2004). 346 
This was supported by ex vivo analyses showing that 1,25(OH)2D is able to suppress 347 
inflammatory cytokine production by endometrial cells from women with unexplained 348 
recurrent spontaneous abortions (Tavakoli, et al. 2011). More recently, 1,25(OH)2D has 349 
been shown to potently regulate natural killer cells from women with recurrent miscarriage 350 
(Ota, et al. 2015). Considering these observations, the impact of maternal vitamin D status 351 
on pregnancy outcome has been studied in several cohorts.  In a large prospective cohort 352 
study of 1683 pregnant women donating serum before gestational week 22, serum 353 
concentrations of 25(OH)D less than 50 nM were associated with a >2-fold increase in first 354 
miscarriage rate, although no significant effect was observed for second trimester 355 
miscarriage (Andersen, et al. 2015). In a prospective study of pre-conceptual vitamin D, 356 
maternal serum 25(OH)D levels were not found to be associated with chances of conceiving 357 
or overall risk of miscarriage (Moller, et al. 2012). However, women with miscarriage in the 358 
second trimester had lower first trimester serum concentrations of 25(OH)D than those 359 
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women who did not miscarry (Moller et al. 2012). In a much larger, nested case-control study 360 
of over 5,000 women did not reveal any adverse effects of low serum 25(OH)D on 361 
pregnancy outcomes (Schneuer, et al. 2014). A recent meta-analysis and systematic review 362 
concluded that vitamin D-deficiency is not associated with increased risk of spontaneous 363 
recurrent abortion (Amegah, et al. 2017).  Thus, the possible impact of sub-optimal vitamin D 364 
on implantation and adverse pregnancy outcomes such as miscarriage still remains unclear. 365 
Interestingly, in endometrial tissue from women with unexplained recurrent spontaneous 366 
abortion, expression of key components in the vitamin D metabolic (CYP27B1/CYP24A1) 367 
and signalling (VDR) systems was found to be comparable to endometrial tissue from 368 
healthy fertile women (Tavakoli, et al. 2015).  By contrast, recent studies of women with 369 
recurrent miscarriage showed that expression of mRNA and protein for CYP27B1 in villous 370 
and decidual tissue was lower than in control tissues from normal healthy pregnancies 371 
(Wang, et al. 2016). In future studies it will be important to clarify how variations in the 372 
vitamin D system within the placenta and fetal trophoblast cells affect implantation and the 373 
maintenance of a successful healthy pregnancy.  374 
 375 
A major contributing factor to vitamin D status in pregnant women is obesity, with lower 376 
circulating levels of 25(OH)D being reported in in pregnant women with high body mass 377 
index (BMI), relative to pregnant women with a normal BMI (Bodnar, et al. 2007a; Karlsson, 378 
et al. 2015).  Maternal obesity is associated with adverse health effects for both mother and 379 
child, with increased inflammation has been proposed as an important pathological 380 
mechanism for the detrimental effects of obesity during pregnancy (Denison, et al. 2010; 381 
Pantham, et al. 2015). A role of vitamin D in the process is still unclear. However, given the 382 
established anti-inflammatory effects of vitamin D at the fetal-maternal interface (Tamblyn et 383 
al. 2015) it is possible that some pregnancy effects of obesity are mediated via low 384 
circulating maternal vitamin D.    385 
 386 
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Conclusions 387 
Expression of placental CYP27B1 and VDR at early stages of pregnancy suggests an 388 
important role for vitamin D in placental physiology. In previous studies we have 389 
hypothesized that placental vitamin D may function, at least in part, to promote anti-microbial 390 
and anti-inflammatory immune activity, with both the maternal decidua and fetal trophoblast 391 
contributing to these actions. However, analysis of trophoblast cells ex vivo and in vitro 392 
indicates that vitamin D may have a much broader role in placental function, including the 393 
regulation of trophoblast differentiation and EVT invasion of the decidua and myometrium 394 
(Figure 1). Thus, effects of vitamin D may occur earlier in pregnancy than previously 395 
appreciated, underlining the requirement for adequate vitamin D status across gestation. To 396 
date, studies of vitamin D status (maternal serum 25(OH)D) in pregnancy have tended to 397 
focus on later stages of pregnancy, and associated adverse events such as preterm birth, 398 
gestational diabetes and preeclampsia. Likewise, supplementation trials for vitamin D in 399 
pregnancy have focused on women between 10 and 18 weeks of pregnancy. However, the 400 
responsiveness of trophoblast cells to 1,25(OH)2D, notably effects on EVT invasion, 401 
suggests that further studies of vitamin D and adverse events in early pregnancy are 402 
required. To date there have been a limited number of reports of vitamin D-deficiency and 403 
miscarriage, but these need to be expanded to include more rigorous supplementation trials. 404 
The review we present is supportive of early, pre-conceptual, supplementation with vitamin 405 
D.  406 
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Legend to figure 
Figure 1.  Vitamin D pathway components at the maternal-fetal interface associated 
with implantation. Schematic showing key cell types involved in implantation and 
associated expression of components of the vitamin D system:  vitamin D binding protein 
(DBP); vitamin D receptor (VDR); retinoid X receptor (RXR); vitamin D-25-hydroxylase 
(CYP2R1); 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1); vitamin D-24-hydroxylase 
(CYP24A1); human chorionic gonadotropin (hCG); human prolactin (hPL).  
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Decidua basalis (including inflammatory cells)
Expresses CYP27B1, VDR, CYP24A1 
Vitamin D regulates key target genes associated 
with implantation, promotes immunosuppression, 
and induces decidualisation
Myometrium (including inflammatory cells)
Expresses VDR
Vitamin D regulates myometrial contractile profile, 
and myometrial cell proliferation
Intervillous space – 
maternal blood
Invasive extra-villous 
trophoblast (EVT)
Expresses DBP, CYP24A1, 
VDR, extracellular fibronectin.
Vitamin D promotes EVT 
invasion and anti-bacterial/
anti-inflammatory responses
Syncytiotrophoblast
Expresses CYP27B1, 
VDR, CYP24A1 
Vitamin D promotes anti-
inflammatory and anti-migratory 
function, and regulates 
production of hCG, hPL, 
estradiol and progesterone
Monocellular layer of 
cytotrophoblast
Expresses DBP, VDR, RXRα.
Vitamin D promotes 
anti-bacterial/anti-inflammatory 
responses
Trophoblastic basement membrane
Produces fibronectin, laminin, 
type 4 collagen, hCG
Response to vitamin D unknown
Villous core fetal vessels
Express CYP27B1, CYP2R1 
Response to vitamin D unknown
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